Novavax COVID-19 vaccine could get EU approval next week – FT

Published by
Reuters

(Reuters) -Novavax’s COVID-19 vaccine could receive approval from Europe’s drug regulator next week and subsequently an emergency use listing from the World Health Organization, the Financial Times reported on Thursday, sending shares of the U.S. drugmaker up 7%. A WHO approval could come once the health body issued its own emergency use listing or if the EMA gave it a conditional marketing authorization, the newspaper reported https://www.ft.com/content/a938950e-7f97-46d6-a22c-6933c5634842, citing people familiar with the matter. That could pave the way for the company and its partner, Serum …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *